Close Menu

NEW YORK (GenomeWeb) – OmniSeq and Laboratory Corporation of America have extended their exclusive distribution agreement for OmniSeq's immune profiling and pan-cancer next-generation sequencing tests the companies signed in 2017.

As part of the expanded deal, LabCorp will distribute OmniSeq's Advance and OmniSeq MSI NGS tests. The original deal covered the OmniSeq Comprehensive and Immune Report Card clinical assays.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.